Fig. 4

Determination of anti-oxidant markers in LPS versus treatment groups (a) Determination of catalase concentration (b) Determination of superoxide dismutase concentration (*p < 0.05, **p < 0.01, ***p < 0.001).

Determination of anti-oxidant markers in LPS versus treatment groups (a) Determination of catalase concentration (b) Determination of superoxide dismutase concentration (*p < 0.05, **p < 0.01, ***p < 0.001).